MiR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α

Oncogene

Volumn 34, Issue 37, 2015, Pages 4890-4900

  Xing, F ^a   Sharma, S ^a   Liu, Y ^a   Mo, Y Y ^a   Wu, K ^a   Zhang, Y Y ^b   Pochampally, R ^b   Martinez, L A ^b   Lo, H W ^a   Watabe, K ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MICRORNA; MICRORNA 509; RHO FACTOR; RHOC PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MIRN509 MICRORNA, HUMAN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN METASTASIS; BREAST CANCER; CANCER CELL; CANCER RECURRENCE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENDOTHELIUM CELL; ESSENTIAL GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; METASTASIS FREE SURVIVAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; UPREGULATION; ANIMAL; BRAIN TUMOR; BREAST TUMOR; CELL CULTURE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; MCF 7 CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SECONDARY; TUMOR SUPPRESSOR GENE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEK293 CELLS; HUMANS; MCF-7 CELLS; MICE; MICE, NUDE; MICRORNAS; RHO GTP-BINDING PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84941315036     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.412     Document Type: Article

References (40)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Weigelt B, Peterse JL, van 't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005; 5: 591-602.
3. Eichler AF, Kuter I, Ryan P, Schapira L, Younger J, Henson JW. Survival in patients with brain metastases from breast cancer: the importance of HER-2 status. Cancer 2008; 112: 2359-2367.
4. Bindal RK, Sawaya R, Leavens ME, Lee JJ. Surgical treatment of multiple brain metastases. J Neurosurg 1993; 79: 210-216.
5. Bindal AK, Bindal RK, Hess KR, Shiu A, Hassenbusch SJ, Shi WM et al. Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg 1996; 84: 748-754.
6. Steeg PS, Camphausen KA, Smith QR. Brain metastases as preventive and therapeutic targets. Nat Rev Cancer 2011; 11: 352-363.
7. Arslan C, Dizdar O, Altundag K. Systemic treatment in breast-cancer patients with brain metastasis. Expert Opin Pharmacother 2010; 11: 1089-1100.
8. He L, Hannon GJ. miRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
9. Tie J, Fan D. Big roles of miRNAs in tumorigenesis and tumor development. Histol Histopathol 2011; 26: 1353-1361.
10. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 2010; 17: F19-F36.
11. Bussing I, Slack FJ, Grosshans H. let-7 miRNAs in development, stem cells and cancer. Trends Mol Med 2008; 14: 400-409.
12. Nagpal N, Ahmad HM, Molparia B, Kulshreshtha R. miRNA-191, an estrogenresponsive miRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis 2013; 34: 1889-1899.
13. Bockhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, Yee K et al. miRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nat Commun 2013; 4: 1393.
14. Nie W, Jin L, Wang Y, Wang Z, Guan X. The bioinformatics analysis of miRNAs signatures differentially expressed in HER2(+) versus HER2(-) breast cancers. Cancer Biother Radiopharm 2013; 28: 71-76.
15. Volinia S, Croce CM. Prognostic miRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc Natl Acad Sci USA 2013; 110: 7413-7417.
16. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M et al. miRNAs accurately identify cancer tissue origin. Nat Biotechnol 2008; 26: 462-469.
17. Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 2014; 25: 501-515.
18. van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 2000; 60: 5832-5838.
19. Wheeler AP, Ridley AJ. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 2004; 301: 43-49.
20. Iiizumi M, Bandyopadhyay S, Pai SK, Watabe M, Hirota S, Hosobe S et al. RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer. Cancer Res 2008; 68: 7613-7620.
21. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992; 263: C1-16.
22. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol 2006; 147: S232-S240.
23. Tsao N, Hsu HP, Wu CM, Liu CC, Lei HY. Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis. J Med Microbiol 2001; 50: 812-821.
24. Ramakrishna R, Rostomily R. Seed, soil, and beyond: The basic biology of brain metastasis. Surg Neurol Int 2013; 4: S256-S264.
25. Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celia-Terrassa T et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med 2011; 17: 1101-1108.
26. Okuda H, Xing F, Pandey PR, Sharma S, Watabe M, Pai SK et al. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res 2013; 73: 1434-1444.
27. Arora S, Ranade AR, Tran NL, Nasser S, Sridhar S, Korn RL et al. miRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. Int J Cancer 2011; 129: 2621-2631.
28. Rosenthal DT, Zhang J, Bao L, Zhu L, Wu Z, Toy K et al. RhoC impacts the metastatic potential and abundance of breast cancer stem cells. PLoS ONE 2012; 7: e40979.
29. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004; 4: 448-456.
30. Wilhelm I, Molnar J, Fazakas C, Hasko J, Krizbai IA. Role of the blood-brain barrier in the formation of brain metastases. Int J Mol Sci 2013; 14: 1383-1411.
31. Izraely S, Sagi-Assif O, Klein A, Meshel T, Tsarfaty G, Pasmanik-Chor M et al. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis. Int J Cancer 2012; 131: 1071-1082.
32. Wang W, Lv S, Zhou Y, Fu J, Li C, Liu P. Tumor necrosis factor-alpha affects blood-brain barrier permeability in acetaminophen-induced acute liver failure. Eur J Gastroenterol Hepatol 2011; 23: 552-558.
33. Yang GY, Gong C, Qin Z, Liu XH, Lorris Betz A. Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res Mol Brain Res 1999; 69: 135-143.
34. Saija A, Princi P, Lanza M, Scalese M, Aramnejad E, De Sarro A. Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sci 1995; 56: 775-784.
35. Yang YL, Li JP, Xu XP, Dou KF, Yue SQ, Li KZ. Protective effects of tumor necrosis factor alpha antibody and ulinastatin on liver ischemic reperfusion in rats. World J Gastroenterol 2004; 10: 3161-3164.
36. Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012; 489: 91-100.
37. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX et al. Genes that mediate breast cancer metastasis to the brain. Nature 2009; 459: 1005-1009.
38. Langley RR, Ramirez KM, Tsan RZ, Van Arsdall M, Nilsson MB, Fidler IJ. Tissuespecific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis. Cancer Res 2003; 63: 2971-2976.
39. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989; 77: 51-59.
40. Bandyopadhyay S, Wang Y, Zhan R, Pai SK, Watabe M, Iiizumi M et al. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res 2006; 66: 11983-11990.